logo

RLYB

RallybioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

RLYB fundamentals

Rallybio (RLYB) released its earnings on Aug 7, 2025: revenue was 212.00K (YoY -29.33%), beat estimates; EPS was -0.22 (YoY +67.16%), beat estimates.
Revenue / YoY
212.00K
-29.33%
EPS / YoY
-0.22
+67.16%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.
EPS
Revenue

Revenue & Expenses

RLYB has released its 2025 Q3 earnings report, with revenue of 212.00K, reflecting a YoY change of -29.10%, and net profit of 16.02M, showing a YoY change of 239.68%. The Sankey diagram below clearly presents RLYB's revenue sources and cost distribution.

Key Indicators

Rallybio (RLYB) key financial stats and ratios, covering profitability, financial health, and leverage.
Rallybio (RLYB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Rallybio (RLYB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Rallybio (RLYB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Rallybio (RLYB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Rallybio (RLYB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield